BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34711629)

  • 21. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial.
    Pinsky PF; Parnes HL; Andriole G
    BJU Int; 2014 Feb; 113(2):254-9. PubMed ID: 24053621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Prostate Cancer-related Death Following a Low PSA Level in the PLCO Trial.
    Landy R; Houghton LC; Berg CD; Grubb RL; Katki HA; Black A
    Cancer Prev Res (Phila); 2020 Apr; 13(4):367-376. PubMed ID: 31996370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Cross AJ; Sinha R; Wood RJ; Xue X; Huang WY; Yeager M; Hayes RB; Gunter MJ
    Cancer Prev Res (Phila); 2011 Sep; 4(9):1465-75. PubMed ID: 21685236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen metabolism and risk of breast cancer in postmenopausal women.
    Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
    J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer.
    Loftfield E; Falk RT; Sampson JN; Huang WY; Hullings A; Murphy G; Weinstein SJ; Albanes D; Freedman ND; Sinha R
    JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35583137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.
    Lai GY; Giovannucci EL; Pollak MN; Peskoe SB; Stampfer MJ; Willett WC; Platz EA
    Cancer Causes Control; 2014 May; 25(5):625-32. PubMed ID: 24664287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study.
    Han P; Bidulescu A; Barber JR; Zeisel SH; Joshu CE; Prizment AE; Vitolins MZ; Platz EA
    Cancer Causes Control; 2019 Apr; 30(4):343-354. PubMed ID: 30825046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein and risk of lung cancer.
    Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
    J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
    J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
    Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
    Eur Urol; 2019 Jul; 76(1):33-40. PubMed ID: 30301696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
    J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.
    Zheng Q; Peskoe SB; Ribas J; Rafiqi F; Kudrolli T; Meeker AK; De Marzo AM; Platz EA; Lupold SE
    Prostate; 2014 Dec; 74(16):1655-62. PubMed ID: 25252191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomic profile of prostate cancer-specific survival among 1812 Finnish men.
    Huang J; Zhao B; Weinstein SJ; Albanes D; Mondul AM
    BMC Med; 2022 Oct; 20(1):362. PubMed ID: 36280842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.
    Andreotti G; Karami S; Pfeiffer RM; Hurwitz L; Liao LM; Weinstein SJ; Albanes D; Virtamo J; Silverman DT; Rothman N; Moore LE
    Epigenetics; 2014 Mar; 9(3):404-15. PubMed ID: 24316677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
    Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.